U.s. Fda Advisers May Vote On Potential Narrower Recommendation Of Pfizer Covid-19 Booster Doses After Rejecting Boosters In Those 16 And Up

U.S. FDA ADVISERS MAY VOTE ON POTENTIAL NARROWER RECOMMENDATION OF PFIZER COVID-19 BOOSTER DOSES AFTER REJECTING BOOSTERS IN THOSE 16 AND UP